Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 49 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/1/1988


1.		Phase II/III Study of IFN-beta-ser/IFN-gamma Followed by DDP/VP-16 in Patients with Inoperable non-Small Cell Lung Cancer (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over								WCCC-CO-8751 NCI-V87-0225

Last Modified: 9/1/2002


2.		Phase III Randomized Study of Conventional Radiotherapy with vs without IFN-B in Patients with Locally Advanced non-Small Cell Lung Cancer (Summary Last Modified 09/02)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				RTOG-9304 RTOG-93-04


3.		Pilot Phase I-II Evaluation of Human Fibroblast Interferon for Disseminated Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								MDA-MBDT-7866

Last Modified: 7/1/1996


4.		Phase I/II Study of Radiotherapy with IFN-B Radiosensitization for Malignant Glioma (Summary Last Modified 07/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Other				URCC-4393MR NCI-V94-0600


5.		Phase I-II Immunotherapy with Human Leukocyte & Fibroblast Interferon for Breast, Bronchogenic, and Colon Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				16 to 75								WCCC-CO-8091


6.		Phase I/II Immunotherapy with Intravesicular Beta-Interferon in Patients with Recurrent Superficial Bladder Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over								NBCG-17

Last Modified: 3/1/1988


7.		Phase I/II Study of Intraventricular IFN-beta-ser in Patients with Carcinomatous Meningitis (Summary Last Modified 03/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over								UAB-387 NCI-V87-0160

Last Modified: 8/1/1993


8.		Phase I/II Pilot Study of Intravenous IFN-B and Hyperfractionated Radiotherapy in Children with Newly Diagnosed Brainstem Gliomas (Summary Last Modified 08/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				2 to 18				NCI				CCG-0912

Last Modified: 12/1/2001


9.		Phase II Study of Recombinant Human Interferon Beta-1a (Avonex) in Patients with Recurrent Gliomas or Astrocytomas (Summary Last Modified 12/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MDA-NCNSC-96314 NCI-T94-0125, T94-0125

Last Modified: 9/20/2007 First Published: 5/1/1998


10.		Phase II Study of Radiotherapy Followed by Recombinant Interferon Beta in Patients with Supratentorial Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				RTOG-9710 RTOG-97-10

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute